Merlisa C Kemp
Overview
Explore the profile of Merlisa C Kemp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaftha M, Robertson F, van Rensburg S, Kidd M, van Toorn R, Kemp M, et al.
Mult Scler Int
. 2024 Nov;
2024:8818934.
PMID: 39524062
: Cerebral white matter lesion (WML) formation in people with multiple sclerosis (pwMS) is linked to the death of myelin-producing oligodendrocytes. Current MS treatment strategies focus on limiting WML accumulation...
2.
Johannes C, Moremi K, Kemp M, Whati L, Engel-Hills P, Kidd M, et al.
Per Med
. 2023 May;
20(2):107-130.
PMID: 37194915
Lipid metabolism may impact disability in people with multiple sclerosis (pwMS). Fifty-one pwMS entered an ultrasound and MRI study, of whom 19 had followed a pathology-supported genetic testing program for...
3.
Kemp M, Johannes C, van Rensburg S, Kidd M, Isaacs F, Kotze M, et al.
J Med Imaging Radiat Sci
. 2022 Dec;
54(2):247-256.
PMID: 36528497
Background: Although multiple sclerosis (MS) is an immune-related disorder, pharmaceutical interventions targeting the immune system do not stop or reverse disability progression; the major challenge for this condition. Studies show...
4.
van Rensburg S, Hattingh C, Johannes C, Moremi K, Peeters A, van Heerden C, et al.
Metab Brain Dis
. 2021 Apr;
36(6):1183-1184.
PMID: 33909201
No abstract available.
5.
van Rensburg S, van Toorn R, Erasmus R, Hattingh C, Johannes C, Moremi K, et al.
Metab Brain Dis
. 2021 Apr;
36(6):1151-1167.
PMID: 33909200
In this Review (Part I), we investigate the scientific evidence that multiple sclerosis (MS) is caused by the death of oligodendrocytes, the cells that synthesize myelin, due to a lack...
6.
van Rensburg S, Hattingh C, Johannes C, Moremi K, Peeters A, van Heerden C, et al.
Metab Brain Dis
. 2021 Mar;
36(6):1169-1181.
PMID: 33710528
In Part I of this Review we evaluated the scientific evidence for a Metabolic Model of multiple sclerosis (MS). Part II outlines the implementation of an adaptive pathology-supported genetic testing...